375 related articles for article (PubMed ID: 37154876)
21. Cuproptosis and its application in different cancers: an overview.
Xu L; Liu K; Wang F; Su Y
Mol Cell Biochem; 2023 Dec; 478(12):2683-2693. PubMed ID: 36914880
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of cuproptosis and its relevance to distinct diseases.
Lou QM; Lai FF; Li JW; Mao KJ; Wan HT; He Y
Apoptosis; 2024 Jun; ():. PubMed ID: 38824478
[TBL] [Abstract][Full Text] [Related]
23. Proteomics revealed the crosstalk between copper stress and cuproptosis, and explored the feasibility of curcumin as anticancer copper ionophore.
Yang Y; Liang S; Geng H; Xiong M; Li M; Su Q; Jia F; Zhao Y; Wang K; Jiang J; Qin S; Li X
Free Radic Biol Med; 2022 Nov; 193(Pt 2):638-647. PubMed ID: 36395954
[TBL] [Abstract][Full Text] [Related]
24. Cuproptosis: unveiling a new frontier in cancer biology and therapeutics.
Feng Y; Yang Z; Wang J; Zhao H
Cell Commun Signal; 2024 May; 22(1):249. PubMed ID: 38693584
[TBL] [Abstract][Full Text] [Related]
25. Cuproptosis: potential new direction in diabetes research and treatment.
Qu J; Wang Y; Wang Q
Front Endocrinol (Lausanne); 2024; 15():1344729. PubMed ID: 38904034
[TBL] [Abstract][Full Text] [Related]
26. Copper homeostasis and cuproptosis in cardiovascular disease therapeutics.
Yang L; Yang P; Lip GYH; Ren J
Trends Pharmacol Sci; 2023 Sep; 44(9):573-585. PubMed ID: 37500296
[TBL] [Abstract][Full Text] [Related]
27. Cuproptosis and cuproptosis-related genes in rheumatoid arthritis: Implication, prospects, and perspectives.
Zhao J; Guo S; Schrodi SJ; He D
Front Immunol; 2022; 13():930278. PubMed ID: 35990673
[TBL] [Abstract][Full Text] [Related]
28. Copper homeostasis and cuproptosis in mitochondria.
Tian Z; Jiang S; Zhou J; Zhang W
Life Sci; 2023 Dec; 334():122223. PubMed ID: 38084674
[TBL] [Abstract][Full Text] [Related]
29. Targeting cuproplasia and cuproptosis in cancer.
Tang D; Kroemer G; Kang R
Nat Rev Clin Oncol; 2024 May; 21(5):370-388. PubMed ID: 38486054
[TBL] [Abstract][Full Text] [Related]
30. Exploring cuproptosis as a mechanism and potential intervention target in cardiovascular diseases.
Yang Y; Feng Q; Luan Y; Liu H; Jiao Y; Hao H; Yu B; Luan Y; Ren K
Front Pharmacol; 2023; 14():1229297. PubMed ID: 37637426
[TBL] [Abstract][Full Text] [Related]
31. Iron and copper: critical executioners of ferroptosis, cuproptosis and other forms of cell death.
Li Y; Du Y; Zhou Y; Chen Q; Luo Z; Ren Y; Chen X; Chen G
Cell Commun Signal; 2023 Nov; 21(1):327. PubMed ID: 37974196
[TBL] [Abstract][Full Text] [Related]
32. Systematic analysis of the aberrances and functional implications of cuproptosis in cancer.
Li J; Li B; Zhao R; Li G
iScience; 2023 Apr; 26(4):106319. PubMed ID: 36950125
[TBL] [Abstract][Full Text] [Related]
33. Cuproptosis: Mechanism, role, and advances in urological malignancies.
Wu J; He J; Liu Z; Zhu X; Li Z; Chen A; Lu J
Med Res Rev; 2024 Jul; 44(4):1662-1682. PubMed ID: 38299968
[TBL] [Abstract][Full Text] [Related]
34. Current and Future of "Turn-On" Based Small-Molecule Copper Probes for Cuproptosis.
Peng TE; Qiu F; Qu Y; Yu C; Cheng X; Li L
ChemistryOpen; 2023 Sep; 12(9):e202300078. PubMed ID: 37705070
[TBL] [Abstract][Full Text] [Related]
35. Roles and mechanisms of copper homeostasis and cuproptosis in osteoarticular diseases.
Han J; Luo J; Wang C; Kapilevich L; Zhang XA
Biomed Pharmacother; 2024 May; 174():116570. PubMed ID: 38599063
[TBL] [Abstract][Full Text] [Related]
36. Cuproptosis, the novel therapeutic mechanism for heart failure: a narrative review.
Yuan HJ; Xue YT; Liu Y
Cardiovasc Diagn Ther; 2022 Oct; 12(5):681-692. PubMed ID: 36329965
[TBL] [Abstract][Full Text] [Related]
37. A Cuproptosis-Related lncRNAs Signature Could Accurately Predict Prognosis in Patients with Clear Cell Renal Cell Carcinoma.
Zhang W; Wang H; Wang W; Xue H; Qiao M; Song L; Wang S; Ren Z; Ma Z
Anal Cell Pathol (Amst); 2022; 2022():4673514. PubMed ID: 36588797
[TBL] [Abstract][Full Text] [Related]
38. Type-I AIE Photosensitizer Loaded Biomimetic System Boosting Cuproptosis to Inhibit Breast Cancer Metastasis and Rechallenge.
Ning S; Lyu M; Zhu D; Lam JWY; Huang Q; Zhang T; Tang BZ
ACS Nano; 2023 Jun; 17(11):10206-10217. PubMed ID: 37183977
[TBL] [Abstract][Full Text] [Related]
39. Prognostic and immune microenvironment analysis of cuproptosis-related LncRNAs in breast cancer.
Pan Y; Zhang Q; Zhang H; Kong F
Funct Integr Genomics; 2023 Jan; 23(1):38. PubMed ID: 36640225
[TBL] [Abstract][Full Text] [Related]
40. Cuproptosis: emerging biomarkers and potential therapeutics in cancers.
Wang M; Zheng L; Ma S; Lin R; Li J; Yang S
Front Oncol; 2023; 13():1288504. PubMed ID: 38023234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]